About EUROIMMUN UK
EUROIMMUN UK is a subsidiary of EUROIMMUN AG that has been supplying high-quality immunodiagnostic products to the UK market since 2000. In 2018, EUROIMMUN AG joined the Revvity family of companies.
EUROIMMUN UK is based in Wimbledon, London and is home to the International Training Centre (ITC). The company offers a comprehensive range of services, including diagnostic test kits and reagents, automated systems, training, after-sales support and instrument maintenance.
Disease Areas and Expertise
EUROIMMUN UK specialises in the following key diagnostic areas:
Global Reach and Legacy
EUROIMMUN AG, founded in 1987 at the University of Lübeck in Germany, maintains its headquarters in Lübeck, near Hamburg. The company has expanded its presence worldwide with 16 subsidiaries and distributors delivering products to over 3,000 laboratories in 140 countries.
Currently, EUROIMMUN employs more than 3,500 people, including:
Our workforce boasts an impressive proportion of graduates in scientific areas such as natural sciences, medicine, technology, and computer science, reflecting its strong scientific focus.
Research, Innovation, and Technology
EUROIMMUN has earned recognition for its extensive product range and advanced diagnostic technologies, driven by continuous investment in research and development. A cornerstone of EUROIMMUN's innovation is the BIOCHIP technology, introduced in 1983, and the subsequent TITERPLANE technology. This technology enables simultaneous incubation of different substrates within a single reaction field, facilitating comprehensive antibody profiling (multiplex) using indirect immunofluorescence techniques with increased standardisation of incubations across every slide.
EUROIMMUN’s diagnostic repertoire also includes:
Automation is a key focus for the company, as evidenced by the release of the EUROPattern Microscope Live, which provides ultrafast, fully automated immunofluorescence pattern identification. This innovation complements EUROIMMUN's extensive suite of instrumentation and software solutions, such as EUROLabOffice and EUROLineScan.
New Offerings for 2025
From January 1, 2025, Immunodiagnostic Systems (IDS) will become part of EUROIMMUN UK's product portfolio. The IDS instrument platforms—IDS iSYS, IDS i10, and IDS c10—enhance laboratory efficiency through advanced automation. With a strong heritage in endocrinology, including vitamin D testing, IDS brings a robust foundation to expand EUROIMMUN's market-leading menu in all test areas.